Septerna (SEPN) Shares Outstanding (Weighted Average) (2023 - 2026)

Septerna (SEPN) recorded quarterly Shares Outstanding (Weighted Average) of $44.8 million in Q1 2026, up 1.13% quarter-over-quarter from $44.3 million in Q4 2025, and up 1.87% on a YoY basis from $43.9 million in Q1 2025.

Septerna (SEPN) Shares Outstanding (Weighted Average) (2023 - 2026) Analysis & Trends

Septerna's Shares Outstanding (Weighted Average) history runs 4 years deep, the most recent figure standing at $44.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 1.87% year-over-year to $44.8 million; the TTM figure through Mar 2026 stood at $44.8 million (up 1.87% YoY), while the FY2025 annual figure was $44.3 million, up 347.46% from the prior year.
  • Shares Outstanding (Weighted Average) was $44.8 million for Q1 2026 at Septerna, up from $44.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $44.8 million in Q1 2026 to a low of $1.9 million in Q4 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $22.0 million across 4 years, with a median of $9.9 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) surged 1868.31% in 2025, then gained 1.87% in 2026.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $1.9 million in 2023, then surged by 412.87% to $9.9 million in 2024, then jumped by 347.46% to $44.3 million in 2025, then rose by 1.13% to $44.8 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $44.8 million (Q1 2026), $44.3 million (Q4 2025), and $44.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Septerna 1.62 Bn 1.62 Bn - 44.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.76 Mn
Dec 31, 2025 44.26 Mn
Sep 30, 2025 44.34 Mn
Jun 30, 2025 44.05 Mn
Mar 31, 2025 43.94 Mn
Dec 31, 2024 9.89 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 2.28 Mn
Mar 31, 2024 2.23 Mn
Dec 31, 2023 1.93 Mn
Sep 30, 2023 2.01 Mn